Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATRIX: LDE225 + Gemcitabine + Nab-paclitaxel in Pancreatic Cancer
NCT02358161Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Sep 2015
- Primary completion
- Sep 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of sonidegib in pancreatic ductal adenocarcinoma (PDAC), sponsored by University of Amsterdam. Started Sep 2015; status: completed.
02
Drugs
sonidegib
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02358161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358161.